"Nasopharyngeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the NASOPHARYNX.
| Descriptor ID |
D009303
|
| MeSH Number(s) |
C04.588.443.665.710.650 C07.550.350.650 C07.550.745.650 C09.647.710.650 C09.775.350.650 C09.775.549.650
|
| Concept/Terms |
Nasopharyngeal Neoplasms- Nasopharyngeal Neoplasms
- Nasopharyngeal Neoplasm
- Neoplasm, Nasopharyngeal
- Neoplasms, Nasopharyngeal
- Nasopharynx Neoplasms
- Nasopharynx Neoplasm
- Neoplasm, Nasopharynx
- Neoplasms, Nasopharynx
Cancer of Nasopharynx- Cancer of Nasopharynx
- Nasopharynx Cancers
- Nasopharyngeal Cancer
- Cancer, Nasopharyngeal
- Cancers, Nasopharyngeal
- Nasopharyngeal Cancers
- Nasopharynx Cancer
- Cancer, Nasopharynx
- Cancers, Nasopharynx
- Cancer of the Nasopharynx
|
Below are MeSH descriptors whose meaning is more general than "Nasopharyngeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Nasopharyngeal Neoplasms".
This graph shows the total number of publications written about "Nasopharyngeal Neoplasms" by people in this website by year, and whether "Nasopharyngeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 3 | 1 | 4 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 3 | 4 |
| 2023 | 1 | 1 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nasopharyngeal Neoplasms" by people in Profiles.
-
Evaluating the Efficacy of Different Treatment Intensities in Nasopharyngeal Carcinoma Patients: A Nationwide Cancer Registry-Based Study. Ann Surg Oncol. 2024 Dec; 31(13):9125-9133.
-
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial. Ann Oncol. 2024 Dec; 35(12):1181-1190.
-
Planet of the apex. Surv Ophthalmol. 2024 May-Jun; 69(3):495-498.
-
Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30574.
-
Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers. BMC Cancer. 2020 Sep 24; 20(1):917.
-
CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett. 2021 01 01; 496:41-56.
-
Neuroimaging Characteristics of Nasopharyngeal Carcinoma in Children. J Neuroimaging. 2021 01; 31(1):137-143.
-
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis. FASEB J. 2020 06; 34(6):8012-8027.
-
Juvenile Nasopharyngeal Angiofibroma Outcomes and Cost: Analysis of the Kids' Inpatient Database. Ann Otol Rhinol Laryngol. 2020 May; 129(5):498-504.
-
Nasopharyngeal Leiomyoma. Ear Nose Throat J. 2019 Feb; 98(2):74-75.